For example, mutations in U2AF1, SRSF2, ZRSR2, and SF3B1 have been identified in myelodysplastic syndromes, chronic lymphocytic leukemia, uveal melanoma, and breast cancer8–19. Here, SF3B1 is linked to myelodysplastic syndrome.